FREE SHIPPING ON ORDERS OVER $150

glutathione platinum resistance A platinum(IV) prodrug strategy to overcome glutathione-based oxaliplatin Platinum-resistant ovarian cancer: mapping mechanisms

$27.92

Quantity
- +
Description

Blockage of CD44 in CSC-enriched cells CSC-enriched 4T1 cells were cultured in 8-well confocal plates under hypoxic condition

glutathione platinum resistance A platinum(IV) prodrug strategy to overcome glutathione-based oxaliplatin Platinum-resistant ovarian cancer: mapping mechanisms

The gr overexpression strain and a control strain (wild type carrying plasmid pJRD215) were also successfully constructed using the method described in the previous section

glutathione platinum resistance A platinum(IV) prodrug strategy to overcome glutathione-based oxaliplatin Platinum-resistant ovarian cancer: mapping mechanisms

European Journal of Drug Metabolism and Pharmacokinetics , 43 (5), pp.495-508

glutathione platinum resistance A platinum(IV) prodrug strategy to overcome glutathione-based oxaliplatin Platinum-resistant ovarian cancer: mapping mechanisms

3.2.2.2 SIRT2 Diabetic kidney disease

glutathione platinum resistance A platinum(IV) prodrug strategy to overcome glutathione-based oxaliplatin Platinum-resistant ovarian cancer: mapping mechanisms

University of Pittsburgh, 2/28-29 The treatment of thoracic fractures

glutathione platinum resistance A platinum(IV) prodrug strategy to overcome glutathione-based oxaliplatin Platinum-resistant ovarian cancer: mapping mechanisms

10.1073/pnas.95.25.15066 [DOI] [PMC free article] [PubMed] [Google Scholar] 80.Maldonado-Avils JG, Curley AA, Hashimoto T, Morrow AL, Ramsey AJ, ODonnell P, et al

glutathione platinum resistance A platinum(IV) prodrug strategy to overcome glutathione-based oxaliplatin Platinum-resistant ovarian cancer: mapping mechanisms

You may also like

recommand products

Frontiers

US$ 23.18

Min. order: 1 piece

4.9 (19 reviews)

Sold : Login>>